Author

A.R. Parikh

Institutions: Harvard University, Massachusetts General Hospital

Observed institutions: Harvard University, Cancer Treatment Centers of America, Thomas Jefferson University Hospital, Massachusetts General Hospital

OpenAlex ID: A5111815606

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

2025 · J.M. Riedl, F. Fece de la Cruz, et al. · Annals of Oncology · 70

Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations

2022 · K. Murugesan, A. Necchi, et al. · ESMO Open · 39

Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours

2019 · R.B. Corcoran, K.T. Do, et al. · Annals of Oncology · 17

Long-Term Outcomes of Definitive Chemoradiation with Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials

2024 · G. Lee, B. Nelson, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

100P Co-mutational landscape of key fibroblast growth factor receptor (FGFR) alterations in intra-hepatic cholangiocarcinoma (iCCA), bladder cancer (BC) and glioma

2022 · A. Necchi, K. Murugesan, et al. · Annals of Oncology · 1

Mutational landscape of metastatic cancers discovered from prospective clinical sequencing at community practice cancer program

2018 · R.H. Alvarez, A. Moran, et al. · Annals of Oncology · 1

Knowledge and Understanding of Treatment Options among Patients with Gastrointestinal (GI) Cancer in an Academic Cancer Center

2022 · E. Kaslow-Zieve, L. Ly, et al. · International Journal of Radiation Oncology*Biology*Physics

High Baseline TNF-α Levels may Associate with Poor Outcomes after Total Neoadjuvant Therapy for Gastroesophageal Cancer: Initial Biomarker Analysis from a Prospective Study

2022 · J.Y. Wo, S. Klempner, et al. · International Journal of Radiation Oncology*Biology*Physics

97P Pan-cancer landscape of clonal tumor mutational burden (cTMB)

2022 · A.R. Parikh, K. Murugesan, et al. · Annals of Oncology

Dose Escalation Radiation with IORT for Unresectable Pancreatic Cancer in the Era of FOLFIRINOX

2020 · H.J. Roberts, C. Grassberger, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 10

Citation count: 129

H-index: 3

I10-index: 3